Financials in USD. Standardized financial statements.
A compact view of how NeuroPace, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $99.99M | $79.91M | $65.42M | $45.52M | $45.18M | $41.14M | $36.97M |
| Revenue Growth? | +25.1% | +22.1% | +43.7% | +0.7% | +9.8% | +11.3% | 0.0% |
| Cost of Revenue? | $22.77M | $20.82M | $17.30M | $13.03M | $11.75M | $10.87M | $10.51M |
| Gross Profit? | $77.22M | $59.09M | $48.12M | $32.49M | $33.44M | $30.27M | $26.46M |
| Gross Margin? | +77.2% | +73.9% | +73.6% | +71.4% | +74.0% | +73.6% | +71.6% |
| Operating Expenses? | $93.56M | $80.76M | $75.30M | $73.29M | $57.17M | $43.32M | $48.49M |
| Operating Income? | -$16.34M | -$21.67M | -$27.17M | -$40.79M | -$23.74M | -$13.05M | -$22.03M |
| EBITDA? | -$14.39M | -$16.57M | -$22.83M | -$36.57M | -$28.37M | -$12.48M | -$20.07M |
| Income Before Tax | -$21.46M | -$27.14M | -$32.96M | -$47.08M | -$36.08M | -$24.28M | -$29.97M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$21.46M | -$27.14M | -$32.96M | -$47.08M | -$36.08M | -$24.28M | -$29.97M |
| EPS? | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | $-2.17 | $-2.70 |
| Diluted EPS? | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | $-2.17 | $-2.70 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality